ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,012Medicare Part D Prescriptions Filled, Including Refills

Rank: 69 out of 337

$528K Total Retail Price of All Prescriptions

Rank: 62 out of 337

462 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 462 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 462 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 9,194 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SIMVASTATIN 331 311 1 1
OMEPRAZOLE 329 300 2 4
LISINOPRIL 305 296 3 2
HYDROCODONE-ACETAMINOPHEN 253 183 S3 4 13
METOPROLOL TARTRATE 220 217 5 6
AMLODIPINE BESYLATE 218 205 6 3
FUROSEMIDE 213 213 7 8
LEVOTHYROXINE SODIUM 206 194 8 5
ATENOLOL 177 169 9 10
TRAZODONE HCL 175 152 10 16
METFORMIN HCL 173 154 11 12
HYDROCHLOROTHIAZIDE 167 162 12 9
GLIMEPIRIDE 165 161 13 55
WARFARIN SODIUM 161 157 14 11
CITALOPRAM HBR 157 137 15 17
TRIAMTERENE-HCTZ 141 139 16 39
ATORVASTATIN CALCIUM 139 138 17 7
TAMSULOSIN HCL 136 136 18 25
GABAPENTIN 130 112 19 20
ALLOPURINOL 130 125 19 28
SERTRALINE HCL 126 111 21 18
PREDNISONE 122 117 22 40
ZOLPIDEM TARTRATE 117 100 23 23
CRESTOR 103 92 24 29
TRAMADOL HCL 101 84 25 32
PRAVASTATIN SODIUM 100 97 26 14
ALENDRONATE SODIUM 90 90 27 19
VERAPAMIL ER 88 88 28 77
LOVASTATIN 84 84 29 24
RANITIDINE HCL 83 83 30 30
METOPROLOL SUCCINATE 80 80 31 21
EXELON 77 77 32 85
MIRTAZAPINE 76 76 33 27
CLOPIDOGREL 75 67 34 42
POLYETHYLENE GLYCOL 3350 72 71 35 47
SYNTHROID 71 71 36 41
KLOR-CON M20 70 57 37 65
PROAIR HFA 69 50 38 38
METFORMIN HCL ER 63 61 39 52
ADVAIR DISKUS 63 50 39 44
JANUVIA 63 60 39 81
LISINOPRIL-HYDROCHLOROTHIAZIDE 63 63 39 31
DONEPEZIL HCL 62 62 43 22
CYMBALTA 59 33 44 59
IBUPROFEN 59 47 44 64
DIGOXIN 57 57 46 58
DIOVAN 54 54 47 26
RAMIPRIL 53 49 48 80
GLYBURIDE 53 46 R 48 53
PEN NEEDLE 52 47 50 236
WELCHOL 51 51 51 178
AVODART 50 50 52 319
POTASSIUM CHLORIDE 50 50 52 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.